Pages that link to "Q33538157"
Jump to navigation
Jump to search
The following pages link to Clinical implications of p53 mutations (Q33538157):
Displaying 50 items.
- The Bloom syndrome protein interacts and cooperates with p53 in regulation of transcription and cell growth control (Q24292118) (← links)
- Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma (Q24649847) (← links)
- [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells (Q24654171) (← links)
- Jasmonates induce nonapoptotic death in high-resistance mutant p53-expressing B-lymphoma cells (Q24676240) (← links)
- Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin (Q24801155) (← links)
- Impaired DNA replication within progenitor cell pools promotes leukemogenesis. (Q24816866) (← links)
- Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach (Q26849477) (← links)
- Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes (Q28247124) (← links)
- Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography (Q28540769) (← links)
- Heterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research database. (Q30377322) (← links)
- Influence of p53 and bcl-2 on chemosensitivity in benign and malignant prostatic cell lines (Q30783266) (← links)
- Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management (Q30891423) (← links)
- Irradiation selects for p53-deficient hematopoietic progenitors. (Q30979212) (← links)
- Genetic mechanisms in squamous cell carcinoma of the head and neck (Q31889996) (← links)
- COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations (Q33689438) (← links)
- The multiple facets of drug resistance: one history, different approaches (Q33697116) (← links)
- Apoptosis in cancer (Q33846227) (← links)
- Sigma receptors: recent advances and new clinical potentials (Q33919837) (← links)
- Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells (Q33964769) (← links)
- Cancer stem cells as targets for cancer therapy: selected cancers as examples. (Q34199130) (← links)
- No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma (Q34234165) (← links)
- How apoptosis is regulated, and what goes wrong in cancer (Q34290061) (← links)
- Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. (Q34390964) (← links)
- Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death? (Q34400252) (← links)
- The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth (Q34402080) (← links)
- P53-responsive genes and the potential for cancer diagnostics and therapeutics development (Q34423327) (← links)
- Apoptosis: a link between cancer genetics and chemotherapy (Q34520432) (← links)
- Role of molecular biology in the follow-up of patients who have Barrett's esophagus (Q34569515) (← links)
- Ionizing radiation and hematopoietic malignancies: Altering the adaptive landscape (Q34582047) (← links)
- A protein turnover signaling motif controls the stimulus-sensitivity of stress response pathways (Q34611097) (← links)
- Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides (Q35078721) (← links)
- Molecular pathogenesis of head and neck squamous cell carcinoma (Q35123594) (← links)
- Methods for screening tumors for p53 status and therapeutic exploitation. (Q35142162) (← links)
- Deletion of p53 in human mammary epithelial cells causes chromosomal instability and altered therapeutic response (Q35188897) (← links)
- INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. (Q35208402) (← links)
- Signaling from p53 to NF-kappa B determines the chemotherapy responsiveness of neuroblastoma (Q35575152) (← links)
- Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers (Q35583968) (← links)
- Nuclear factor-κB as a predictor of treatment response in breast cancer (Q35587283) (← links)
- Control of apoptosis by p53. (Q35603381) (← links)
- Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway (Q35728921) (← links)
- Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. (Q35840327) (← links)
- Exploiting the p53 pathway for the diagnosis and therapy of human cancer. (Q36547790) (← links)
- Serum p53 antibodies: predictors of survival in small-cell lung cancer? (Q36621503) (← links)
- Neem oil limonoids induces p53-independent apoptosis and autophagy. (Q36647000) (← links)
- Replicational stress selects for p53 mutation (Q36672150) (← links)
- DNA damage response and development of targeted cancer treatments (Q36939423) (← links)
- Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities (Q36960756) (← links)
- p53: a molecular marker for the detection of cancer. (Q37248542) (← links)
- Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo (Q37478104) (← links)
- Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. (Q37536938) (← links)